Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Triscari

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Journal of Clinical Pharmacology|February 1, 1992
Single-dose pharmacokinetics of pravastatin and metabolites in patients with renal impairmentC E Halstenson, J Triscari, A DeVault, et al.
American Journal of Hypertension|September 10, 1999
Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertensionM Kochar, R Guthrie, J Triscari, et al.
Journal of Lipid Research|October 1, 1985
Decreased hepatic production of very low density lipoproteins following activation of fatty acid oxidation by Ro 22-0654M Yamamoto, N Fukuda, J Triscari, et al.
The American Journal of Physiology|May 1, 1984
Effects of diet and obesity on brown adipose metabolismB E Levin, M B Finnegan, E Marquet, et al.
British Journal of Clinical Pharmacology|September 1, 1993
Steady state serum concentrations of pravastatin and digoxin when given in combinationJ Triscari, B N Swanson, D A Willard, et al.
Clinical Therapeutics|July 15, 1998
An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan. Irbesartan/Losartan Study InvestigatorsS Oparil, R Guthrie, A J Lewin, et al.
The American Journal of Physiology|December 11, 1984
Diet-dependent hyperplastic growth of adipose tissue in hypothalamic obese ratsI M Faust, W H Miller, A Sclafani, et al.
Physiology & Behavior|January 1, 1987
Infusion of cholecystokinin between meals into free-feeding rats fails to prolong the intermeal intervalD B West, M R Greenwood, A C Sullivan, et al.
Diabetes, Obesity & Metabolism|January 3, 2013
The efficacy and safety of ezetimibe/simvastatin combination compared with intensified lipid-lowering treatment strategies in diabetic subjects with and without metabolic syndromeJ G Jimenez, J B Rosen, V Pirags, et al.
International Journal of Obesity|January 1, 1987
Studies on the antiobesity activity of tetrahydrolipstatin, a potent and selective inhibitor of pancreatic lipaseS Hogan, A Fleury, P Hadvary, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Journal of Clinical Pharmacology|February 1, 1992
Single-dose pharmacokinetics of pravastatin and metabolites in patients with renal impairmentC E Halstenson, J Triscari, A DeVault, et al.
American Journal of Hypertension|September 10, 1999
Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertensionM Kochar, R Guthrie, J Triscari, et al.
Journal of Lipid Research|October 1, 1985
Decreased hepatic production of very low density lipoproteins following activation of fatty acid oxidation by Ro 22-0654M Yamamoto, N Fukuda, J Triscari, et al.
The American Journal of Physiology|May 1, 1984
Effects of diet and obesity on brown adipose metabolismB E Levin, M B Finnegan, E Marquet, et al.
British Journal of Clinical Pharmacology|September 1, 1993
Steady state serum concentrations of pravastatin and digoxin when given in combinationJ Triscari, B N Swanson, D A Willard, et al.
Clinical Therapeutics|July 15, 1998
An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan. Irbesartan/Losartan Study InvestigatorsS Oparil, R Guthrie, A J Lewin, et al.
The American Journal of Physiology|December 11, 1984
Diet-dependent hyperplastic growth of adipose tissue in hypothalamic obese ratsI M Faust, W H Miller, A Sclafani, et al.
Physiology & Behavior|January 1, 1987
Infusion of cholecystokinin between meals into free-feeding rats fails to prolong the intermeal intervalD B West, M R Greenwood, A C Sullivan, et al.
Diabetes, Obesity & Metabolism|January 3, 2013
The efficacy and safety of ezetimibe/simvastatin combination compared with intensified lipid-lowering treatment strategies in diabetic subjects with and without metabolic syndromeJ G Jimenez, J B Rosen, V Pirags, et al.
International Journal of Obesity|January 1, 1987
Studies on the antiobesity activity of tetrahydrolipstatin, a potent and selective inhibitor of pancreatic lipaseS Hogan, A Fleury, P Hadvary, et al.
Pageof 5